IMARC Group has recently released a report titled “End-Stage Renal Disease Market: Analysis of Epidemiology, Industry Trends, Size, Share, and Future Forecast (2023-2033)” that presents a comprehensive assessment of the end-stage renal disease market size. The report provides an extensive overview of the latest market trends, growth prospects, investment opportunities, and industry outlook, as well as an in-depth analysis of the disease landscape, market size, and growth trends. Furthermore, the report offers an analysis of competitors, regional markets, and recent advancements in the market. It also sheds light on crucial segments and market drivers, along with challenges faced by industry players. This report is a valuable resource for stakeholders who want to gain valuable insights into the end-stage renal disease market.
End-stage renal disease, or renal failure, is the last stage of chronic kidney disease, in which the functioning ability of the kidneys drops to extremely low levels. As the ailments lead to failure of the kidneys’ filtering functions, harmful fluids, toxins, and electrolytes can accumulate in the body. The common symptoms of end-stage renal disease include nausea, loss of appetite, weight loss, fatigue, muscle cramps, bone pain, numbness in the feet, hands, or other areas, edema, excessive thirst, frequent hiccups, etc. The diagnosis of this condition involves a series of tests, such as blood tests, urine tests, ultrasounds, CT scans, and a kidney biopsy.
Request a Free Sample Report: https://www.imarcgroup.com/end-stage-renal-disease-market/requestsample
The growing cases of diabetes and high blood pressure, which directly impact the blood vessels in the kidneys, are primarily driving the end-stage renal disease market. Moreover, the rising occurrences of urinary tract disorders, like kidney stones that weaken the kidneys over time, are further augmenting the market growth. In addition to this, the introduction of effective medications, such as diuretics, calcium carbonate, recombinant human erythropoietin, etc., that help treat the underlying symptoms of end-stage renal disease is creating a positive outlook for the market.
Furthermore, several government bodies are taking initiatives to enhance healthcare accessibility for patients with renal failure, including increasing financial resources for dialysis centers and reimbursement rates for providers, which in turn, is acting as another significant growth-inducing factor. Additionally, the rising popularity of antidiabetic drugs for treating end-stage renal disease, as they have the potential to mitigate the risk of ailment progression, is expected to propel the end-stage renal disease market in the coming years.
Report Period:
- Base Year: 2022
- Historical Period: 2017-2022
- Market Forecast: 2023-2033
Countries Included:
- United States
- Germany
- France
- United Kingdom
- Italy
- Spain
- Japan
Analysis Covered Across Each Country
- Historical, current, and future epidemiology scenario
- Historical, current, and future performance of the end-stage renal disease market
- Historical, current, and future performance of various therapeutic categories in the market
- Sales of various drugs across the end-stage renal disease market
- Reimbursement scenario in the market
- In-market and pipeline drugs
In-Market Drugs
- Drug Overview
- Mechanism of Action
- Regulatory Status
- Clinical Trial Results
- Drug Uptake and Market Performance
Late-Stage Pipeline Drugs
- Drug Overview
- Mechanism of Action
- Regulatory Status
- Clinical Trial Results
- Regulatory Status
Ask an Analyst for Report Customization with TOC & List of figures: https://www.imarcgroup.com/end-stage-renal-disease-market
Key Questions Answered in this Report:
- How has the end-stage renal disease market performed so far and how will it perform in the coming years?
- What are the markets shares of various therapeutic segments in 2022 and how are they expected to perform till 2033?
- What was the country-wise size of the end-stage renal disease market across the seven major markets in 2022 and what will it look like in 2033?
- What is the growth rate of the end-stage renal disease market across the seven major markets and what will be the expected growth over the next ten years?
- What are the key unmet needs in the market?
Browse the Latest Research Report:
Keratoconus Market Report 2023-2033
Follicular Lymphoma Market Report 2023-2033
Chemotherapy Induced Pain Market Report 2023-2033
Endometrial Cancer Market Report 2023-2033
About Us: –
IMARC Group is a leading market research company that offers management strategy and market research worldwide. We partner with clients in all sectors and regions to identify their highest-value opportunities, address their most critical challenges, and transform their businesses.
IMARC’s information products include major market, scientific, economic and technological developments for business leaders in pharmaceutical, industrial, and high technology organizations. Market forecasts and industry analysis for biotechnology, advanced materials, pharmaceuticals, food and beverage, travel and tourism, nanotechnology and novel processing methods are at the top of the company’s expertise.
Contact US
IMARC Group
134 N 4th St.
Brooklyn, NY 11249, USA
Email: Sales@imarcgroup.com
Americas:- +1 631 791 1145 | Africa and Europe :- +44-702-409-7331 | Asia: +91-120-433-0800, +91-120-433-0800
